Literature DB >> 23490163

T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells.

Thomas Hoyler1, Catherine A Connor, Elina A Kiss, Andreas Diefenbach.   

Abstract

Innate lymphoid cells (ILCs) are an emerging group of innate lymphocytes that share functional and transcriptional attributes with the various T helper cell effector fates (e.g. Th1, Th2, Th17). ILCs are substantially represented in the intestinal mucosa but are rare in secondary lymphoid organs. They play important roles in epithelial homeostasis, tissue repair and in immunity to intestinal infections. They are also involved in immune-mediated pathology. Here, we will review the emerging roles of the transcription factors T-bet and Gata3 in the development, lineage specification and function of distinct ILC lineages. We will also highlight the requirement of these transcriptional programs for the control of infections and the pathogenesis of inflammatory diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490163     DOI: 10.1016/j.coi.2013.02.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  12 in total

1.  Innate lymphoid cells in the defense against infections.

Authors:  Andreas Diefenbach
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-09-23

2.  A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene.

Authors:  Zuoqing Li; Neng Yang; Ling Zhou; Peng Gu; Hui Wang; Yun Zhou; Peijun Zhou; Liming Lu; Kuang-Yen Chou
Journal:  Immunology       Date:  2016-03       Impact factor: 7.397

3.  ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.

Authors:  Hadi Maazi; Nisheel Patel; Ishwarya Sankaranarayanan; Yuzo Suzuki; Diamanda Rigas; Pejman Soroosh; Gordon J Freeman; Arlene H Sharpe; Omid Akbari
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

Review 4.  Migration and Tissue Tropism of Innate Lymphoid Cells.

Authors:  Chang H Kim; Seika Hashimoto-Hill; Myunghoo Kim
Journal:  Trends Immunol       Date:  2015-12-18       Impact factor: 16.687

5.  Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.

Authors:  Jonathan S Silver; Jennifer Kearley; Alan M Copenhaver; Caroline Sanden; Michiko Mori; Li Yu; Gretchen Harms Pritchard; Aaron A Berlin; Christopher A Hunter; Russell Bowler; Jonas S Erjefalt; Roland Kolbeck; Alison A Humbles
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

6.  Roles of Type 1, 2, and 3 Innate Lymphoid Cells in Herpes Simplex Virus 1 Infection In Vitro and In Vivo.

Authors:  Satoshi Hirose; Shaohui Wang; Kati Tormanen; Yizhou Wang; Jie Tang; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

7.  Modulation of Signal Strength Switches Notch from an Inducer of T Cells to an Inducer of ILC2.

Authors:  Rebecca Gentek; J Marius Munneke; Christina Helbig; Bianca Blom; Mette D Hazenberg; Hergen Spits; Derk Amsen
Journal:  Front Immunol       Date:  2013-10-22       Impact factor: 7.561

8.  Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation.

Authors:  Bobby W S Li; Ralph Stadhouders; Marjolein J W de Bruijn; Melanie Lukkes; Dior M J M Beerens; Maarten D Brem; Alex KleinJan; Ingrid Bergen; Heleen Vroman; Mirjam Kool; Wilfred F J van IJcken; Tata Nageswara Rao; Hans Jörg Fehling; Rudi W Hendriks
Journal:  Front Immunol       Date:  2017-12-01       Impact factor: 7.561

Review 9.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

10.  Anti-proliferative Activity of T-bet.

Authors:  Yeon Ji Oh; Ji Hyun Shin; Hee Yeon Won; Eun Sook Hwang
Journal:  Immune Netw       Date:  2015-08-26       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.